Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT06681051Recruiting

Effectiveness and Safety of OSTENIL® TENDON in the Treatment of Pain and Restricted Mobility in Tendon Disorders

Role: lead

NCT03809962Completed

Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

Role: lead

NCT03879434Completed

Routine Application of Ostenil® Mini in Patients with Rhizarthrosis

Role: lead

NCT03734315Completed

Routine Application of Ostenil® in Patients with Gonarthrosis

Role: lead

NCT04757051Completed

Real-life Use of BENART TM in Patients With Symptomatic Knee Osteoarthritis

Role: lead

NCT03494140Completed

Viscontour® Serum Med in Hydration of Facial Skin

Role: lead

NCT02908282Not ApplicableCompleted

Topical Omega-3 Fatty Acids (REMOGEN® OMEGA) in the Treatment of Dry Eye

Role: lead

NCT01791062Not ApplicableCompleted

Safety and Efficacy Study of HYTOP® in the Treatment of Focal Chondral Defects.

Role: lead

NCT02332109Completed

ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy

Role: lead

NCT01954108Not ApplicableCompleted

Hyaluronan in the Treatment of Painful Achilles Tendinopathy.

Role: lead

NCT01482624Not ApplicableCompleted

Intra-articular Hyaluronan After Arthroscopic Meniscal Surgery

Role: lead

NCT01254682Not ApplicableCompleted

Intra-articular Hyaluronan Substitution in Arthroscopy of the Wrist

Role: lead

NCT01290510Not ApplicableCompleted

Hyaluronan in the Treatment of Painful Tendinopathy

Role: lead

All 13 trials loaded